These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 26861241)
41. The Structural Properties in Solution of the Intrinsically Mixed Folded Protein Ataxin-3. Sicorello A; Kelly G; Oregioni A; Nováček J; Sklenář V; Pastore A Biophys J; 2018 Jul; 115(1):59-71. PubMed ID: 29972812 [TBL] [Abstract][Full Text] [Related]
42. Schwann cell involvement in the peripheral neuropathy of spinocerebellar ataxia type 3. Suga N; Katsuno M; Koike H; Banno H; Suzuki K; Hashizume A; Mano T; Iijima M; Kawagashira Y; Hirayama M; Nakamura T; Watanabe H; Tanaka F; Sobue G Neuropathol Appl Neurobiol; 2014 Aug; 40(5):628-39. PubMed ID: 23617879 [TBL] [Abstract][Full Text] [Related]
43. p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons. Chou AH; Lin AC; Hong KY; Hu SH; Chen YL; Chen JY; Wang HL Neurochem Int; 2011 Feb; 58(2):145-52. PubMed ID: 21092747 [TBL] [Abstract][Full Text] [Related]
44. Interaction of ataxin-3 with huntingtin-associated protein 1 through Josephin domain. Takeshita Y; Fujinaga R; Kokubu K; Islam MN; Jahan MR; Yanai A; Kakizuka A; Shinoda K Neuroreport; 2011 Mar; 22(5):232-8. PubMed ID: 21386698 [TBL] [Abstract][Full Text] [Related]
45. Local protein unfolding and pathogenesis of polyglutamine-expansion diseases. Chen YW Proteins; 2003 Apr; 51(1):68-73. PubMed ID: 12596264 [TBL] [Abstract][Full Text] [Related]
46. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells. Tsai HF; Tsai HJ; Hsieh M Biochem Biophys Res Commun; 2004 Nov; 324(4):1274-82. PubMed ID: 15504352 [TBL] [Abstract][Full Text] [Related]
47. Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3). Hübener J; Weber JJ; Richter C; Honold L; Weiss A; Murad F; Breuer P; Wüllner U; Bellstedt P; Paquet-Durand F; Takano J; Saido TC; Riess O; Nguyen HP Hum Mol Genet; 2013 Feb; 22(3):508-18. PubMed ID: 23100324 [TBL] [Abstract][Full Text] [Related]
48. Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3. Rodrigues AJ; Coppola G; Santos C; Costa Mdo C; Ailion M; Sequeiros J; Geschwind DH; Maciel P FASEB J; 2007 Apr; 21(4):1126-36. PubMed ID: 17234717 [TBL] [Abstract][Full Text] [Related]
49. Dynamic expression of Hsp27 in the presence of mutant ataxin-3. Chang WH; Cemal CK; Hsu YH; Kuo CL; Nukina N; Chang MH; Hu HT; Li C; Hsieh M Biochem Biophys Res Commun; 2005 Oct; 336(1):258-67. PubMed ID: 16126176 [TBL] [Abstract][Full Text] [Related]
51. Ataxin-2: A versatile posttranscriptional regulator and its implication in neural function. Lee J; Kim M; Itoh TQ; Lim C Wiley Interdiscip Rev RNA; 2018 Nov; 9(6):e1488. PubMed ID: 29869836 [TBL] [Abstract][Full Text] [Related]
52. ATXN2 is a target of N-terminal proteolysis. Chitre M; Emery P PLoS One; 2023; 18(12):e0296085. PubMed ID: 38128014 [TBL] [Abstract][Full Text] [Related]
54. Structure validation of the Josephin domain of ataxin-3: conclusive evidence for an open conformation. Nicastro G; Habeck M; Masino L; Svergun DI; Pastore A J Biomol NMR; 2006 Dec; 36(4):267-77. PubMed ID: 17096206 [TBL] [Abstract][Full Text] [Related]
55. The 2.2-Angstrom resolution crystal structure of the carboxy-terminal region of ataxin-3. Zhemkov VA; Kulminskaya AA; Bezprozvanny IB; Kim M FEBS Open Bio; 2016 Mar; 6(3):168-78. PubMed ID: 27047745 [TBL] [Abstract][Full Text] [Related]
56. Characterization of the conformational fluctuations in the Josephin domain of ataxin-3. Sanfelice D; De Simone A; Cavalli A; Faggiano S; Vendruscolo M; Pastore A Biophys J; 2014 Dec; 107(12):2932-2940. PubMed ID: 25517158 [TBL] [Abstract][Full Text] [Related]